SPC
BMY icon

Spirepoint Private Client’s Bristol-Myers Squibb BMY Stock Holding History

Spirepoint Private Client’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,725
Closed -$265K – 281
2025
Q2 		$265K Sell
5,725
-110
-2% -$5.4K 0.03% 201
2025
Q1 		$356K Sell
5,835
-12
-0.2% -$699 0.05% 162
2024
Q4 		$331K Buy
5,847
+904
+18% +$50.5K 0.04% 170
2024
Q3 		$256K Sell
4,943
-3,970
-45% -$186K 0.03% 184
2024
Q2 		$370K Sell
8,913
-413
-4% -$18.5K 0.05% 158
2024
Q1 		$506K Buy
+9,326
New +$475K 0.08% 127

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spirepoint Private Client's BMY Position: Q3 2025 in Review

Spirepoint Private Client sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 5,725 shares — an estimated $265K sold.

Spirepoint Private Client first reported a position in BMY in Q1 2024 and held it in 6 quarters. The position peaked at $506K in Q1 2024. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Spirepoint Private Client reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Spirepoint Private Client sold 5,725 Bristol-Myers Squibb shares in Q3 2025, an estimated $265K.
  • Spirepoint Private Client first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 6 quarters.
  • Spirepoint Private Client's Bristol-Myers Squibb position peaked at $506K in Q1 2024.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Spirepoint Private Client's 13F filing for Q3 2025, filed 22 Oct 2025.